These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis. Ferrell PB; Aitcheson CT; Pearson GR; Tan EM J Clin Invest; 1981 Mar; 67(3):681-7. PubMed ID: 6259207 [TBL] [Abstract][Full Text] [Related]
25. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia]. Okano M Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855 [TBL] [Abstract][Full Text] [Related]
26. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma. Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043 [TBL] [Abstract][Full Text] [Related]
27. Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen. Dillner J; Sternås L; Kallin B; Alexander H; Ehlin-Henriksson B; Jörnvall H; Klein G; Lerner R Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4652-6. PubMed ID: 6205400 [TBL] [Abstract][Full Text] [Related]
28. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit]. Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576 [TBL] [Abstract][Full Text] [Related]
29. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity. Incaprera M; Rindi L; Bazzichi A; Garzelli C Clin Exp Rheumatol; 1998; 16(3):289-94. PubMed ID: 9631751 [TBL] [Abstract][Full Text] [Related]
30. Antibodies in rheumatoid arthritis react specifically with the glycine alanine repeat sequence of Epstein-Barr nuclear antigen-1. Baboonian C; Halliday D; Venables PJ; Pawlowski T; Millman G; Maini RN Rheumatol Int; 1989; 9(3-5):161-6. PubMed ID: 2481875 [TBL] [Abstract][Full Text] [Related]
31. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Bray PF; Luka J; Bray PF; Culp KW; Schlight JP Neurology; 1992 Sep; 42(9):1798-804. PubMed ID: 1381067 [TBL] [Abstract][Full Text] [Related]
32. The conserved domain CR2 of Epstein-Barr virus nuclear antigen leader protein is responsible not only for nuclear matrix association but also for nuclear localization. Yokoyama A; Kawaguchi Y; Kitabayashi I; Ohki M; Hirai K Virology; 2001 Jan; 279(2):401-13. PubMed ID: 11162796 [TBL] [Abstract][Full Text] [Related]
34. An Epstein Barr virus-related cross reactive autoimmune response in multiple sclerosis in Norway. Vaughan JH; Riise T; Rhodes GH; Nguyen MD; Barrett-Connor E; Nyland H J Neuroimmunol; 1996 Sep; 69(1-2):95-102. PubMed ID: 8823380 [TBL] [Abstract][Full Text] [Related]
35. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. McClain MT; Rapp EC; Harley JB; James JA J Med Virol; 2003 Jun; 70(2):253-7. PubMed ID: 12696112 [TBL] [Abstract][Full Text] [Related]
36. A human monoclonal autoantibody isolated from a patient with infectious mononucleosis reactive with both self antigens and Epstein-Barr virus nuclear antigen (EBNA). Garzelli C; Pacciardi A; Carmignani M; Conaldi G; Basolo F; Falcone G Immunol Lett; 1989 Sep; 22(3):211-6. PubMed ID: 2478456 [TBL] [Abstract][Full Text] [Related]
37. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man. Milman G; Scott AL; Cho MS; Hartman SC; Ades DK; Hayward GS; Ki PF; August JT; Hayward SD Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6300-4. PubMed ID: 2412231 [TBL] [Abstract][Full Text] [Related]
38. Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man. Falk K; Linde A; Johnson D; Lennette E; Ernberg I; Lundkvist A J Med Virol; 1995 Aug; 46(4):349-57. PubMed ID: 7595412 [TBL] [Abstract][Full Text] [Related]
39. Expression of Epstein-Barr virus nuclear antigen 1,2A and 2B in the baculovirus expression system: serological evaluation of human antibodies to these proteins. Hille A; Klein K; Bäumler S; Grässer FA; Mueller-Lantzsch N J Med Virol; 1993 Mar; 39(3):233-41. PubMed ID: 8385705 [TBL] [Abstract][Full Text] [Related]
40. Detection of Epstein-Barr virus-coded antigens in lymphocytes isolated from defined patient samples. Veltri RW; McClung JE; Sprinkle PM IARC Sci Publ (1971); 1978; (24 Pt 2):729-32. PubMed ID: 221395 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]